Clinical Trial Update: Low Dose Rt-PA for Acute Normotensive Pulmonary Embolism With RVD [Phase 4]

View source ↗

Summary

Clinical trial update describes a Phase 4 study evaluating low-dose alteplase (rt-PA) for acute normotensive pulmonary embolism with right ventricular dysfuncti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Drugs mentioned

• Alteplase (alteplase)

Snippet

Sponsor: Beijing Chao Yang Hospital | Conditions: Pulmonary Thromboembolisms, Pulmonary Embolism | Phase 4 | Status: UNKNOWN